Home »
Academic Articles »
Algorithm »
Rapid profiling of carcinogenic types of Helicobacter pylori infection via deep learning analysis of label-free SERS spectra of human serum
Rapid profiling of carcinogenic types of Helicobacter pylori infection via deep learning analysis of label-free SERS spectra of human serum
Fen Li
(Department of Laboratory Medicine, Huai'an Hospital Affiliated to Yangzhou University (The Fifth People's Hospital of Huai'an), Huai'an, Jiangsu, China)
Yu-Ting Si
(Laboratory Medicine, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China; Medical Technology School, Xuzhou Medical University, Xuzhou, Jiangsu, China)
Jia-Wei Tang
(Laboratory Medicine, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China)
Zeeshan Umar
(Laboratory Medicine, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China; Marshall Laboratory of Biomedical Engineering, International Cancer Center, School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen, Guangdong, China)
Xue-Song Xiong
(Department of Laboratory Medicine, Huai'an Hospital Affiliated to Yangzhou University (The Fifth People's Hospital of Huai'an), Huai'an, Jiangsu, China)
Jin-Ting Wang
(Department of Gastroenterology, Huai'an Hospital Affiliated to Yangzhou University (The Fifth People's Hospital of Huai'an), Huai'an, Jiangsu, China)
Quan Yuan
(Laboratory Medicine, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China; Department of Intelligent Medical Engineering, School of Medical Informatics and Engineering, Xuzhou Medical University, Xuzhou, Jiangsu, China)
Alfred Chin Yen Tay
(Marshall Laboratory of Biomedical Engineering, International Cancer Center, School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen, Guangdong, China; The Marshall Centre for Infectious Diseases Research and Training, University of Western Australia, Perth, Western Australia, Australia; Marshall Medical Research Center, Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China; Marshall International Digestive Diseases Hospital, Zhengzhou University, Zhengzhou, Henan, China)
Eng Guan Chua
(Marshall Laboratory of Biomedical Engineering, International Cancer Center, School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen, Guangdong, China; The Marshall Centre for Infectious Diseases Research and Training, University of Western Australia, Perth, Western Australia, Australia; Marshall Medical Research Center, Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China; Marshall International Digestive Diseases Hospital, Zhengzhou University, Zhengzhou, Henan, China)
Li Zhang
(School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, New South Wales 2052, Australia)
Barry J. Marshall
(Marshall Laboratory of Biomedical Engineering, International Cancer Center, School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen, Guangdong, China; The Marshall Centre for Infectious Diseases Research and Training, University of Western Australia, Perth, Western Australia, Australia; Marshall Medical Research Center, Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China; Marshall International Digestive Diseases Hospital, Zhengzhou University, Zhengzhou, Henan, China)
Wei-Xuan Yang
(Department of Gastroenterology, Huai'an Hospital Affiliated to Yangzhou University (The Fifth People's Hospital of Huai'an), Huai'an, Jiangsu, China; Corresponding authors.)
Bing Gu
(Laboratory Medicine, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China; Corresponding authors.)
Liang Wang
(Laboratory Medicine, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China; Division of Microbiology and Immunology, School of Biomedical Sciences, The University of Western Australia, Crawley, Western Australia, Australia; Centre for Precision Health, School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia; School of Agriculture and Food Sustainability, University of Queensland, Brisbane, Queensland, Australia; Corresponding author at: Laboratory Medicine, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.)
Journal: Computational and Structural Biotechnology Journal
•
• American Association for the Advancement of Science (AAAS)
• ISSN: 2001-0370
Abstract
WHO classified Helicobacter pylori as a Group I carcinogen for gastric cancer as early as 1994. However, despite the high prevalence of H. pylori infection, only about 3 % of infected individuals eventually develop gastric cancer, with the highly virulent H. pylori strains expressing cytotoxin-associated protein (CagA) and vacuolating cytotoxin (VacA) being critical factors in gastric carcinogenesis. It is well known that H. pylori infection is divided into two types in terms of the presence and absence of CagA and VacA toxins in serum, that is, carcinogenic Type I infection (CagA+/VacA+, CagA+/VacA-, CagA-/VacA+) and non-carcinogenic Type II infection (CagA-/VacA-). Currently, detecting the two carcinogenic toxins in active modes is mainly done by diagnosing their serological antibodies. However, the method is restricted by expensive reagents and intricate procedures. Therefore, establishing a rapid, accurate, and cost-effective way for serological profiling of carcinogenic H. pylori infection holds significant implications for effectively guiding H. pylori eradication and gastric cancer prevention. In this study, we developed a novel method by combining surface-enhanced Raman spectroscopy with the deep learning algorithm convolutional neural network to create a model for distinguishing between serum samples with Type I and Type II H. pylori infections. This method holds the potential to facilitate rapid screening of H. pylori infections with high risks of carcinogenesis at the population level, which can have long-term benefits in reducing gastric cancer incidence when used for guiding the eradication of H. pylori infections.
Fen Li, Yu-Ting Si, Jia-Wei Tang, et al. (2024). "Rapid profiling of carcinogenic types of Helicobacter pylori infection via deep learning analysis of label-free SERS spectra of human serum". Computational and Structural Biotechnology Journal. https://doi.org/10.1016/j.csbj.2024.09.008